1,2:3,4-DIBENZANTHRACENE
1,2:3,4-DIBENZANTHRACENE Basic information
- Product Name:
- 1,2:3,4-DIBENZANTHRACENE
- Synonyms:
-
- 94652, Dibenz[a,c]anthracene (purity)
- 1,2,3,4-DIBENZANTHRACENE 97%
- Dibenz[a,c]anthracene solution
- 1,2,3,4-Dibenzanthracene,97%
- 1.2:3.4-Dibenzanthracene 10mg [215-58-7]
- Dibenz[a,c]anthracene,1,2:3,4-Dibenzanthracene
- 1,2,3,4-Dibenzanthracene, 97% 100MG
- 1,2,3,4-1,2,3,4-Dibenzanthracene
- CAS:
- 215-58-7
- MF:
- C22H14
- MW:
- 278.35
- EINECS:
- 205-920-8
- Product Categories:
-
- Aromatic Hydrocarbons (substituted) & Derivatives
- Mol File:
- 215-58-7.mol
1,2:3,4-DIBENZANTHRACENE Chemical Properties
- Melting point:
- 205-207 °C(lit.)
- Boiling point:
- 518 °C(lit.)
- Density
- 1.1489 (estimate)
- refractive index
- 1.8120 (estimate)
- Flash point:
- -18 °C
- storage temp.
- Sealed in dry,2-8°C
- solubility
- Chloroform (Slightly), Ethyl Acetate (Slightly), DMSO (Slightly)
- color
- Clear plates, leaflets or needles from EtOH orAcOH
- Water Solubility
- 1.6ug/L(25 ºC)
- BRN
- 1912415
- CAS DataBase Reference
- 215-58-7(CAS DataBase Reference)
- IARC
- 3 (Vol. Sup 7, 92) 2010
- EPA Substance Registry System
- Dibenz[a,c]anthracene (215-58-7)
Safety Information
- Hazard Codes
- T,N,Xn,F
- Risk Statements
- 23/24/25-50-67-65-50/53-38-11
- Safety Statements
- 36/37-45-61-62-60
- RIDADR
- UN 2811 6.1/PG 3
- WGK Germany
- 3
- RTECS
- DM1925000
- HazardClass
- 6.1(b)
- PackingGroup
- III
- HS Code
- 29029000
- Toxicity
- mma-sat 10 mg/plate PNASA6 72,5135,75
MSDS
- Language:English Provider:SigmaAldrich
- Language:English Provider:ACROS
1,2:3,4-DIBENZANTHRACENE Usage And Synthesis
Chemical Properties
LIGHT YELLOW TO BROWN POWDER
Uses
Dibenzo[a,c]anthracene is a polycyclic aromatic hydrocarbon which are known carcinogens and environmental pollutants.
Definition
ChEBI: Dibenz[a,c]anthracene is a carbopolycyclic compound.
Safety Profile
Questionable carcinogen withexperimental tumorigenic data. Human mutation datareported. When heated to decomposition it emits acridsmoke and irritating fumes.
Carcinogenicity
Dibenz[a,c]anthracene was administered dermally to mice, either per se or as part of initiation–promotion protocols. The working group concluded that there was limited evidence for animal carcinogenicity. In later studies on an initiation–promotion study on mouse skin, low initiating doses gave negative results when administered subcutaneously to mice, and tumor incidence was not significantly increased over that observed in controls when the compound was administered intraperitoneally to newborn mice.
1,2:3,4-DIBENZANTHRACENESupplier
- Tel
- 010-82848833 400-666-7788
- jkinfo@jkchemical.com
- Tel
- 021-61259108 18621169109
- market03@meryer.com
- Tel
- 821-50328103-801 18930552037
- 3bsc@sina.com
- Tel
- 021-021-58432009 400-005-6266
- sales8178@energy-chemical.com
- Tel
- 800-810-5118
- cnchemical@thermofisher.com
1,2:3,4-DIBENZANTHRACENE(215-58-7)Related Product Information
- 1,2:3,4-DIBENZANTHRACENE
- (6,6)-PHENYL C71 BUTYRIC ACID METHYL ESTER, 99% (MIXTURE OF ISOMERS)
- 1.12,2.3,4.5,6.7,8.9,10.11-HEXABENZOCORONENE
- Dibenz[a,h]anthracene
- Triphenylene
- Lin-Dibenzanthracene,2,3,6,7-DIBENZANTHRACENE
- CIRCOBIPHENYL
- TETRABENZ[A,C,H,J]ANTHRACENE
- DIBENZ[A,C]PENTACENE
- OVALENE
- DIBENZO[LMQRS]NAPHTHA[3,2,1,8,7-DEFGH]PHENANTHRO[3,4,5-YZAB]PYRANTHRENE
- DIBENZO(A,E)PYRENE
- NAPHTHO[2,3-E]PYRENE
- 3,4,5,6-Dibenzanthracene
- dibenzanthracene
- ANTHRACENO[2.3-A]CORONENE
- DIBENZO[A,G]CORONENE
- 1.14-BENZOBISANTHENE